Aurobindo Pharma Limited
AUROPHARMA
Helyezés a részvények között
#2068
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Részvényárfolyam
$17.34
Piaci kapitalizáció
$9.98B
Változás (1 nap)
-3.08%
Változás (1 év)
38.71%
Ország
IN
Kereskedés Aurobindo Pharma Limited (AUROPHARMA)
Kategória
Healthcare
EPS Aurobindo Pharma Limited (AUROPHARMA) részvényre
EPS June 2026 dátummal, TTM: $0.71
Aurobindo Pharma Limited legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi EPS mutatója (TTM) $0.71. 2024 végén a vállalat EPS mutatója $0.65 volt, növekedés a 2023 év EPS értékéhez, amely $0.40 volt.
Aurobindo Pharma Limited EPS története 2004 és 2026 között
EPS minden év végén
| Év | EPS | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $0.71 | 0.90% |
| 2025 | $0.70 | 7.68% |
| 2024 | $0.65 | 62.23% |
| 2023 | $0.40 | -32.77% |
| 2022 | $0.60 | -52.13% |
| 2021 | $1.24 | 92.96% |
| 2020 | $0.64 | 10.91% |
| 2019 | $0.58 | -8.50% |
| 2018 | $0.64 | 4.73% |
| 2017 | $0.61 | 15.90% |
| 2016 | $0.52 | 20.94% |
| 2015 | $0.43 | -3.95% |
| 2014 | $0.45 | 384.93% |
| 2013 | $0.09 | -322.25% |
| 2012 | $-0.04 | -119.03% |
| 2011 | $0.22 | -5.22% |
| 2010 | $0.23 | 529.89% |
| 2009 | $0.04 | -66.91% |
| 2008 | $0.11 | 27.82% |
| 2007 | $0.09 | 190.97% |
| 2006 | $0.03 | 1,893.33% |
| 2005 | 0.00 | -97.13% |
| 2004 | $0.05 | 0.00% |
EPS hasonló cégek vagy versenytársak esetén
| Vállalat | EPS | EPS különbség | Ország |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.24% |
IN
|
